Company / Revenue
Lipocine Inc. Revenue History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$11.2M
FY2025
5-year range
-$2.9M / $16.1M
FY2021-FY2025
Trend
+492.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue changed +493% YoY in FY2025, a notable deviation from the 7-year average annual change of +1321%.
Based on SEC 10-K filings.
$11M in FY2025 with a 5-year CAGR of +132.5%.
Improved from $500,000 to $11M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -11.5%
- 5-Year CAGR
- +132.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +132.5%, indicating consistent growth.
- In FY2025, revenue increased 492.8% year-over-year.
- Peak revenue was recorded in FY2022.
- Lowest revenue in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.2M | +492.8% |
| FY2024 | -$2.9M | -670.2% |
| FY2023 | $500.0K | -96.9% |
| FY2022 | $16.1M | +0.0% |
| FY2021 | $16.1M | +9682.9% |
| FY2020 | $165.0K | -61.5% |
| FY2019 | $428.0K | - |
| FY2018 | $0 | -100.0% |
| FY2013 | $7.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026